150 related articles for article (PubMed ID: 27738640)
1. The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain.
Al-Saber F; Aldosari W; Alselaiti M; Khalfan H; Kaladari A; Khan G; Harb G; Rehani R; Kudo S; Koda A; Tanaka T; Nakajima M; Darwish A
J Diabetes Res; 2016; 2016():8294805. PubMed ID: 27738640
[TBL] [Abstract][Full Text] [Related]
2. A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.
Nakamura Y; Haraguchi A; Shigeno R; Ito A; Horie I; Kawakami A; Abiru N
Medicine (Baltimore); 2021 Mar; 100(10):e25100. PubMed ID: 33725905
[TBL] [Abstract][Full Text] [Related]
3. 5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.
Ota U; Hara T; Nakagawa H; Tsuru E; Tsuda M; Kamiya A; Kuroda Y; Kitajima Y; Koda A; Ishizuka M; Fukuhara H; Inoue K; Shuin T; Nakajima M; Tanaka T
BMC Pharmacol Toxicol; 2017 Jan; 18(1):7. PubMed ID: 28132645
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Shimura M; Nozawa N; Ogawa-Tominaga M; Fushimi T; Tajika M; Ichimoto K; Matsunaga A; Tsuruoka T; Kishita Y; Ishii T; Takahashi K; Tanaka T; Nakajima M; Okazaki Y; Ohtake A; Murayama K
Sci Rep; 2019 Jul; 9(1):10549. PubMed ID: 31332208
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Tanaka T; Tashiro M; Ota K; Fujita A; Sawai T; Kadota J; Fukuda Y; Sumiyoshi M; Ide S; Tachikawa N; Fujii H; Hibino M; Shiomi H; Izumida M; Matsui K; Yamauchi M; Takahashi K; Yamanashi H; Sugimoto T; Akabame S; Umeda M; Shimizu M; Hosogaya N; Kosai K; Takeda K; Iwanaga N; Ashizawa N; Hirayama T; Takazono T; Yamamoto K; Imamura Y; Miyazaki T; Kobayashi Y; Ariyoshi K; Mukae H; Yanagihara K; Kita K; Izumikawa K
Medicine (Baltimore); 2023 Aug; 102(34):e34858. PubMed ID: 37653769
[TBL] [Abstract][Full Text] [Related]
6. Sodium ferrous citrate and 5-aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health.
Kitamura N; Zhang S; Morel JD; Nagano U; Taworntawat T; Hosoda S; Nakamura A; Ogawa Y; Benegiamo G; Auwerx J; Tsubota K; Yokoyama Y; Watanabe M
Obesity (Silver Spring); 2023 Apr; 31(4):1038-1049. PubMed ID: 36823345
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.
Kawamura K; Matsushima H; Sakai H; Iwashima A; Nakamura S; Kojima T; Sasaki S; Shigenaga T; Natsume I; Sasaki T; Ohsaki Y; Iwanaga K; Nishi K; Mitsuishi Y; Taniguchi H; Sato K; Yamauchi M; Nakajima M; Takahashi K
Oncology; 2022; 100(11):620-632. PubMed ID: 36099876
[TBL] [Abstract][Full Text] [Related]
8. Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R; Koga T; Shimizu T; Sato S; Tashiro S; Hosogaya N; Yamamoto H; Kawakami A
Medicine (Baltimore); 2020 Dec; 99(50):e22708. PubMed ID: 33327226
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis.
Negoro H; Chatziantonio C; Razzaque MS
Expert Rev Anti Infect Ther; 2022 May; 20(5):657-661. PubMed ID: 34927515
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila.
Nozawa N; Noguchi M; Shinno K; Tajima M; Aizawa S; Saito T; Asada A; Ishii T; Ishizuka M; Iijima KM; Ando K
FEBS Open Bio; 2022 Jan; 12(1):295-305. PubMed ID: 34854258
[TBL] [Abstract][Full Text] [Related]
11. Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women.
Masuki S; Morita A; Kamijo Y; Ikegawa S; Kataoka Y; Ogawa Y; Sumiyoshi E; Takahashi K; Tanaka T; Nakajima M; Nose H
J Appl Physiol (1985); 2016 Jan; 120(1):87-96. PubMed ID: 26514619
[TBL] [Abstract][Full Text] [Related]
12. Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA).
Rehani PR; Iftikhar H; Nakajima M; Tanaka T; Jabbar Z; Rehani RN
J Diabetes Res; 2019; 2019():4267357. PubMed ID: 31781665
[TBL] [Abstract][Full Text] [Related]
13. Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.
Hara T; Koda A; Nozawa N; Ota U; Kondo H; Nakagawa H; Kamiya A; Miyashita K; Itoh H; Nakajima M; Tanaka T
FEBS Open Bio; 2016 Jun; 6(6):515-28. PubMed ID: 27239432
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Hu X; Que W; Hirano H; Wang Z; Nozawa N; Ishii T; Ishizuka M; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Guo WZ; Li XK
Cancer Sci; 2021 Jul; 112(7):2652-2663. PubMed ID: 33934440
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
Miyake M; Tanaka N; Asakawa I; Yamaki K; Inoue T; Suzuki S; Hori S; Nakai Y; Anai S; Torimoto K; Toritsuka M; Nakagawa H; Tsukamoto S; Fujii T; Ohbayashi C; Hasegawa M; Kasahara M; Fujimoto K
Contemp Clin Trials Commun; 2020 Sep; 19():100593. PubMed ID: 32637724
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
Ann Intern Med; 2012 Mar; 156(6):405-15. PubMed ID: 22431673
[TBL] [Abstract][Full Text] [Related]
17. [Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin].
Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S27-38. PubMed ID: 23529568
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron.
Ito H; Nishio Y; Hara T; Sugihara H; Tanaka T; Li XK
Eur J Pharmacol; 2018 Aug; 833():25-33. PubMed ID: 29753693
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade.
Zhao M; Zhu P; Fujino M; Nishio Y; Chen J; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhao L; Zhuang J; Li XK
Biochem Biophys Res Commun; 2016 Oct; 479(4):663-669. PubMed ID: 27693692
[TBL] [Abstract][Full Text] [Related]
20. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Liu C; Wang Z; Hu X; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Li XK
Int Immunopharmacol; 2021 Jul; 96():107626. PubMed ID: 33862551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
